Establishing a Global Brand Identity for a New MS Therapy
ChallengeBiogen, a leader in multiple sclerosis (MS) research and treatment, was in need of establishing a global brand identity for their new MS therapy, ZINBRYTA. Our task was to develop a brand identity that distinguishes ZINBRYTA from other MS therapies and works in domestic and global markets, including the EU and Russia.
We designed a flexible and dynamic brand identity for ZINBRYTA and developed a brand kit for Biogen’s partner agencies around the world that provides clear guidance and tools for ensuring a strong global brand presence in multiple languages.
Disease / Therapy
Multiple Sclerosis (MS) / Zinbryta
Brand Global Guidelines/Standards
Packaging/Insert Design Guidelines
Zinbryta Brand Color Strategy
A distinctive color palette was created to differentiate ZINBRYTA from other MS therapies and reflects the brand attributes of confidence, strength, and empowerment. The color palette was developed early on in the brand strategy phase and applied to the product design of ZINBRYTA’s delivery mechanism.
Zinbryta LogoThe ZINBRYTA logo communicates the distinct characteristics, regulatory requirements, and brand expression of ZINBRYTA. Multiple variations of the logo were created to address its use in context and media.
Zinbryta Logo TranslationsTranslations of the ZINBRYTA logo achieve consistency across a spectrum of languages.
Zinbryta Visual System
The ZINBRYTA brand identity included a comprehensive visual system of brand assets, including logos, typography, imagery, color palette, graphic elements, icons, information graphics, charts, and graphs created for future ZINBRYTA marketing communications and digital initiatives.